Enhancing cancer registry data for comparative effectiveness research (CER) project: overview and methodology.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of registry management

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 25419602PMCID PMC4524450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Black race independently predicts worse survival in uterine carcinosarcoma.

  2014cited by this paper
• Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

  2014cited by this paper
• Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.

  2014cited by this paper
• Treatment Patterns for Prostate Cancer: Comparison of Medicare Claims Data to Medical Record Review

  2014cited by this paper
• Impact of facility volume on therapy and survival for locally advanced cervical cancer.

  2014cited by this paper
• Race Does Not Impact Pancreatic Cancer Treatment and Survival in an Equal Access Federal Health Care System

  2013cited by this paper
• Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.

  2012cited by this paper
• Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

  2012cited by this paper
• Defining care provided for breast cancer based on medical record review or Medicare claims: information from the Centers for Disease Control and Prevention Patterns of Care Study.

  2012cited by this paper
• Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study.

  2011cited by this paper
• Developing a Claim-based Version of the ACE-27 Comorbidity Index: A Comparison With Medical Record Review

  2011cited by this paper
• Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?

  2011cited by this paper
• Methods for improving cancer surveillance data in American Indian and Alaska Native populations

  2008cited by this paper
• Rationale and design of the National Program of Cancer Registries' breast, colon, and prostate cancer patterns of care study

  2004cited by this paper
• Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

  2002cited by this paper
• Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer.

  2002cited by this paper
• AJCC cancer staging handbook : from the AJCC cancer staging manual

  2002cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Enhancing Data Systems to Improve the Quality of Cancer Care

  2000cited by this paper
• International Classification of Diseases for Oncology: ICD-0.

  2000cited by this paper
• Ensuring Quality Cancer Care

  1999cited by this paper
• The National Comprehensive Cancer Network

  1998cited by this paper
• Measuring social class in US public health research: concepts, methodologies, and guidelines.

  1997cited by this paper
• The American Joint Committee on Cancer.

  1984cited by this paper

• Revolutionizing Cancer Registries: The Promise and Challenges of Integrating Molecular Markers for Enhanced Patient Care and Research.

  2025cites this paper
• Impact of social determinants on the development, diagnosis, and treatment of cancer: recommended public health interventions.

  2025cites this paper
• Feasibility of Clinically Prioritized Colorectal Cancer Quality Indicators With a New South Wales Population-Based Linked Dataset.

  2025cites this paper
• Challenges and Solutions of Cancer Registries: A Scoping Review.

  2025cites this paper
• Patterns and Differences in Lung Cancer Treatment - United States, 2015-2020.

  2024cites this paper
• Breast and colorectal cancer recurrence-free survival estimates in the US: Modeling versus active data collection.

  2023cites this paper
• Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow

  2023cites this paper
• Treatment and Survival in Acute Leukemia: A New South Wales Study Comparing Adolescents and Young Adults with Children and Adults

  2023cites this paper
• Development and Demonstration of Tobacco Treatment Measures for Cancer Registries: Novel Metrics for Quality Improvement.

  2023cites this paper
• Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.

  2022cites this paper
• Examining the Landscape of Prognostic Factors and Clinical Outcomes for Cancer Control

  2021cites this paper
• Impact of diabetes and modifiable risk factors on pancreatic cancer survival in a population-based study after adjusting for clinical factors

  2021cites this paper
• Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients

  2020influential citation
• Breast and colorectal cancer recurrence and progression captured by five U.S. population-based registries: Findings from National Program of Cancer Registries patient-centered outcome research.

  2020cites this paper
• Prevalence of Cigarette Smoking among Patients with Different Histologic Types of Kidney Cancer

  2020cites this paper
• Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.

  2019cites this paper
• Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.

  2019cites this paper
• Identifying Smoking Status and Smoking Cessation Using a Data Linkage Between the Kentucky Cancer Registry and Health Claims Data.

  2019cites this paper
• Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative

  2018cites this paper
• Angela C Eckstrand

  2018cites this paper
• Data-Adaptive Estimation for Double-Robust Methods in Population-Based Cancer Epidemiology: Risk Differences for Lung Cancer Mortality by Emergency Presentation

  2018cites this paper
• CancerLinQ: Origins, Implementation, and Future Directions.

  2018cites this paper
• Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

  2018cites this paper
• Capture of tobacco use among population‐based registries: Findings from 10 National Program of Cancer Registries states

  2018cites this paper
• The history and use of cancer registry data by public health cancer control programs in the United States

  2017cites this paper
• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

  2017cites this paper
• Capture and coding of industry and occupation measures: Findings from eight National Program of Cancer Registries states

  2017influential citation
• KRAS testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United States.

  2017influential citation
• CDC’s Public Health Surveillance of Cancer

  2017cites this paper
• PREVENTING CHRONIC DISEASE

  2017cites this paper
• The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data.

  2016cites this paper
• The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients

  2016cites this paper
• Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.

  2016cites this paper
• Ovarian Cancer Treatment Decisions: Accessing Gynecologic Oncology Care

  2016cites this paper
• Population-Based Testing and Treatment Characteristics for Chronic Myelogenous Leukemia.

  2016cites this paper
• Commentary: Ascertaining Late Effects of Breast Cancer and Its Treatment: Can We Build a Better Mouse Trap?

  2016cites this paper
• Connecting the Dots: Linking the National Program of Cancer Registries and the Needs of Survivors and Clinicians.

  2015cites this paper
• Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base

  2015cites this paper